Janet E Olson

Author PubWeight™ 149.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007 29.23
2 A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 2007 7.35
3 Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009 7.30
4 Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 2008 6.22
5 Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med 2010 6.04
6 Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2010 4.54
7 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013 4.35
8 Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 2009 4.13
9 Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 2013 3.81
10 Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. J Natl Cancer Inst 2009 2.88
11 Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk. Hepatology 2012 2.33
12 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res 2012 1.81
13 Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status. Arch Intern Med 2006 1.77
14 AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiol Biomarkers Prev 2007 1.75
15 Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet 2010 1.74
16 Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Res Treat 2010 1.70
17 Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res 2011 1.65
18 Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 2009 1.58
19 Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet 2013 1.56
20 Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res 2010 1.51
21 Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2008 1.39
22 Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet 2013 1.39
23 Inherited determinants of ovarian cancer survival. Clin Cancer Res 2010 1.32
24 Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2009 1.29
25 CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. J Clin Oncol 2012 1.29
26 Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis 2013 1.28
27 A novel automated mammographic density measure and breast cancer risk. J Natl Cancer Inst 2012 1.28
28 A method for automatically interpreting mass spectra of 18O-labeled isotopic clusters. Mol Cell Proteomics 2006 1.27
29 11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat 2012 1.26
30 Estrogen bioactivation, genetic polymorphisms, and ovarian cancer. Cancer Epidemiol Biomarkers Prev 2005 1.25
31 Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev 2011 1.23
32 The role of genetic breast cancer susceptibility variants as prognostic factors. Hum Mol Genet 2012 1.23
33 Interaction of waist/hip ratio and family history on the risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Am J Epidemiol 2002 1.20
34 Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality. J Natl Cancer Inst 2007 1.17
35 Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. J Natl Cancer Inst 2010 1.17
36 Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer. Cancer Res 2010 1.14
37 A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer. Gastroenterology 2002 1.14
38 Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One 2012 1.13
39 Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2002 1.12
40 The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort. Breast Cancer Res 2012 1.11
41 Fruit and vegetable consumption is inversely associated with having pancreatic cancer. Cancer Causes Control 2011 1.10
42 Automated discovery of drug treatment patterns for endocrine therapy of breast cancer within an electronic medical record. J Am Med Inform Assoc 2011 1.09
43 Risk factors for meningioma in postmenopausal women: results from the Iowa Women's Health Study. Neuro Oncol 2011 1.06
44 Genetic variation in the chromosome 17q23 amplicon and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2009 1.05
45 Relative weight at age 12 and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2008 1.03
46 Association of genetic variation in mitotic kinases with breast cancer risk. Breast Cancer Res Treat 2009 1.02
47 A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Hum Mol Genet 2013 1.00
48 Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Res 2014 0.99
49 Nutrients from fruit and vegetable consumption reduce the risk of pancreatic cancer. J Gastrointest Cancer 2013 0.97
50 High-folate diets and breast cancer survival in a prospective cohort study. Nutr Cancer 2002 0.97
51 Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel. Hum Mol Genet 2013 0.97
52 Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls. Cancer Epidemiol Biomarkers Prev 2010 0.91
53 BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst 2015 0.90
54 Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer. Breast Cancer Res Treat 2011 0.90
55 Association of family history of specific cancers with a younger age of onset of pancreatic adenocarcinoma. Clin Gastroenterol Hepatol 2006 0.90
56 Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. Hum Genet 2014 0.89
57 Identification of a novel percent mammographic density locus at 12q24. Hum Mol Genet 2012 0.88
58 DNA mismatch repair gene MSH6 implicated in determining age at natural menopause. Hum Mol Genet 2013 0.88
59 Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk. Mol Carcinog 2010 0.86
60 Fatty acids found in dairy, protein and unsaturated fatty acids are associated with risk of pancreatic cancer in a case-control study. Int J Cancer 2013 0.86
61 Does folate intake decrease risk of postmenopausal breast cancer among women with a family history? Cancer Causes Control 2004 0.85
62 ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer. BMC Cancer 2014 0.84
63 Racial differences in primary central nervous system lymphoma incidence and survival rates. Neuro Oncol 2009 0.83
64 Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study. Endocr Relat Cancer 2013 0.83
65 Mammographic breast density response to aromatase inhibition. Clin Cancer Res 2013 0.82
66 CYP2B6*6 is associated with increased breast cancer risk. Int J Cancer 2013 0.82
67 Hospitalizations and emergency department use in Mayo Clinic Biobank participants within the employee and community health medical home. Mayo Clin Proc 2013 0.81
68 Interaction of adolescent anthropometric characteristics and family history on breast cancer risk in a Historical Cohort Study of 426 families (USA). Cancer Causes Control 2004 0.81
69 Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006 0.81
70 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium. J Med Genet 2011 0.80
71 Meat-related mutagens and pancreatic cancer: null results from a clinic-based case-control study. Cancer Epidemiol Biomarkers Prev 2013 0.80
72 Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy. Breast Cancer Res 2015 0.79
73 The effect of grape seed extract on estrogen levels of postmenopausal women: a pilot study. J Diet Suppl 2014 0.78
74 The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant. Breast Cancer Res Treat 2011 0.76
75 Evaluation of the Aromatase Inhibition Potential of Freeze-Dried Grape Powder. J Diet Suppl 2014 0.76
76 No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density. Breast Cancer Res 2012 0.75
77 Predicting Cesarean Delivery After Induction of Labor Among Nulliparous Women at Term. Obstet Gynecol 2015 0.75
78 Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome. BMC Med Genomics 2014 0.75
79 Reply: To PMID 23055147. Hepatology 2013 0.75
80 Localized provoked vestibulodynia: outcomes after modified vestibulectomy. J Reprod Med 2014 0.75